No seven-year itch here: After spending the better part of a decade putting aside their differences to team up on the combination of their respective patient monitoring technologies, Philips and ...
Multi-Year Partnership Renewal with Broadened Focus Will Include Expedited Technology Adoption and Market-Based Strategic Development of Next-Generation Monitoring Solutions IRVINE, Calif., September ...
On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.
Medtech companies Philips and Masimo are expanding their patient monitoring partnership to include the latter's new W1 wearable. The collaboration allows vital sign data from the W1 watch to be sent ...
Amsterdam, the Netherlands and Irvine California – Masimo (NASDAQ: MASI) and Royal Philips (NYSE: PHG; AEX: PHIA), both global leaders in patient monitoring, announced today that they have reinforced ...
Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...
Multi-Year Partnership Renewal with Broadened Focus Will Include Expedited Technology Adoption and Market-Based Strategic Development of Next-Generation Monitoring Solutions Building on over two ...
Multi-Year Partnership Renewal with Broadened Focus Will Include Expedited Technology Adoption and Market-Based Strategic Development of Next-Generation Monitoring Solutions Masimo (NASDAQ: MASI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback